Yoshihisa Kawai

Ube, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.

The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer.

Journal: Cell reports

Published: April 05, 2025

Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer.

Paternally Expressed Gene 10 (PEG10) Promotes Growth, Invasion, and Survival of Bladder Cancer.

Journal: Molecular cancer therapeutics

Published: October 31, 2019

ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer.

ARHGAP29 expression may be a novel prognostic factor of cell proliferation and invasion in prostate cancer.

Journal: Oncology reports

Published: July 15, 2019

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma.

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma.

Journal: Oncotarget

Published: November 03, 2017

Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma.

Extracellular miR-224 as a prognostic marker for clear cell renal cell carcinoma.

Journal: Oncotarget

Published: July 19, 2017

The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer.

The Efficacy of Trimodal Chemoradiotherapy with Cisplatin as a Bladder-Preserving Strategy for the Treatment of Muscle-Invasive Bladder Cancer.

Journal: Urologia internationalis

Published: February 07, 2017

Germline DNA copy number variations as potential prognostic markers for non-muscle invasive bladder cancer progression.

Germline DNA copy number variations as potential prognostic markers for non-muscle invasive bladder cancer progression.

Journal: Oncology letters

Published: December 28, 2016

Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer.

Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer.

Journal: Japanese journal of clinical oncology

Published: October 03, 2016

Factors Prognostic for Survival in Japanese Patients Treated with Sunitinib as First-line Therapy for Metastatic Clear Cell Renal Cell Cancer.

Factors Prognostic for Survival in Japanese Patients Treated with Sunitinib as First-line Therapy for Metastatic Clear Cell Renal Cell Cancer.

Journal: Asian Pacific journal of cancer prevention : APJCP

Published: September 01, 2015

BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.

BUBR1 overexpression predicts disease-specific survival after nephroureterectomy in patients with upper tract urothelial carcinoma.

Journal: Japanese journal of clinical oncology

Published: August 03, 2015

siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer.

siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: April 10, 2015

Clinical significance of ERG rearrangement subtype and its association with increased p53 expression in Japanese and German prostate cancer.

Clinical significance of ERG rearrangement subtype and its association with increased p53 expression in Japanese and German prostate cancer.

Journal: Neoplasma

Published: January 17, 2015

Showing 1-12 of 16

Last Updated: 09/26/2026